 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Caprion Leading $21M Clinical Biomarker and Personalized Medicine Development Project
February 22, 2013
Caprion Leading $21M Clinical Biomarker and Personalized Medicine Development Project
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- MRM-MS 'Core' to Caprion's Protein Dx Strategy in Wake of Acquisition by Chicago Growth Partners
July 27, 2012 / ProteoMonitor - 2012 Sees Rise of Targeted Proteomics and DIA-MS, Continued Clinical Push by Big Industry Players
January 4, 2013 / ProteoMonitor - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - New Vendor Collaborations, Publications, Products Suggest Clinical Mass Spec 'Ready for Prime Time'
February 15, 2013 / ProteoMonitor - Targeted Mass Spec Slowly but Steadily Moving Toward Broader Commercial, Clinical Adoption
September 21, 2012 / ProteoMonitor